Biotech

All Articles

Biogen, UCB report period 3 lupus win after falling short earlier test

.Biogen and also UCB's bank on improving into phase 3 astride an unsuccessful research study seeks t...

Aptadir wishes new RNA preventions can turn around difficult cancers

.Italian biotech Aptadir Therapeutics has introduced along with the pledge that its pipe of preclini...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Wave Life Sciences has met its own target in a Duchenne muscle dystrophy (DMD) study, installing it...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, occupyi...

Achilles droplets cell treatment plan, supports for unemployments after overlooking 'office stability' goals

.Achilles Therapeutics has actually shreded its technique. The British biotech is actually stopping ...

Aligos proclaims phase 2 MASH succeed, slashing liver excess fat approximately 46%

.Aligos Therapeutics is actually advertising a midstage win in metabolic-dysfunction linked steatohe...

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job establishing brand new antifungals has actually obtained a notable incr...

Capricor sells Europe legal rights to late-stage DMD treatment for $35M

.Possessing actually scooped up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne mus...

FDA scraps adcomm for Applied's unusual disease medicine

.After dismissing the decision meeting for Applied Therapeutics' metabolic ailment drug govorestat, ...

Novo inks $600M NanoVation deal to research hereditary drugs ex-liver

.Novo Nordisk is proceeding its press right into hereditary medications, agreeing to pay NanoVation ...